Fig. 6.
Proportion of changes in imaging assessment and postoperative pathologic TRG response between different SII-PNI score groups. (A) CT imaging changes after 2 cycles of chemotherapy with the preoperative neoadjuvant chemotherapy regimen of XELOX, as assessed by RECIST version 1.1; (B) CT imaging changes after 2 cycles of chemotherapy with the preoperative neoadjuvant chemotherapy regimen of SOX, as assessed by RECIST version 1.1; (C) distribution of postoperative pathological TRG grading in patients with a SII-PNI score of 0; (D) distribution of postoperative pathological TRG grading in patients with a SII- distribution of postoperative pathologic TRG grading in patients with a PNI score of 1; (E) distribution of postoperative pathologic TRG grading in patients with a SII-PNI score of 2
